The FDA Has Approved The First Condom Designed Particularly For Anal Intercourse

 The FDA Has Approved The First Condom Designed Particularly For Anal Intercourse

This week, the U.S. Food and Drug Administration authorized the first condom that is designated for anal sex alone.

The One Male Condom is the first to be given permission to use the "safe and effective use" designation for decreasing sexually transmitted illnesses during anal sex, while not being noticeably different from the hundreds of other condoms on the market. Additionally, it is authorized for use as a contraceptive and as a tool to lower STIs during vaginal sex.

On a statement, Davin Wedel, president and founder of Boston-based Global Protection Corp, producer of the One Male Condom, said, "This momentous move proves that when researchers, advocates, and companies come together, we can create a lasting influence in public health efforts." "More than 300 condoms have been certified for use with data from vaginal intercourse, but a condom has never been approved based on anal sex data."

The risk of STI transmission during anal intercourse is "substantially higher" than during vaginal intercourse, according to Courtney Lias, director of the FDA's Office of GastroRenal, ObGyn, General Hospital and Urology Devices.

Lias stated in a statement that the FDA's approval of a condom that is explicitly suggested, assessed, and labeled for anal intercourse "may improve the likelihood of condom use during anal intercourse." Additionally, this permission enables us to advance health equity by creating products that are both safe and effective and satisfy the requirements of a variety of communities.

The risk of catching HIV is highest during anal sex, which is around 18 times more likely than vaginal sex to transmit the virus. According to the Centers for Disease Control and Prevention, men who identify as gay or bisexual made up 69 percent of the 36,801 new HIV/AIDS diagnoses in the United States in 2019. According to the CDC, queer men of color were overrepresented in this group, with Black men accounting for 37%, Latino men for 32%, and white men for 25% of these new diagnoses.

One Male Condoms come in three basic varieties: thin, fitting, and standard. The fitted variety comes in 54 various sizes.

According to the FDA, which defined condom failure as condom slippage or breakage, a clinical investigation of 252 men who have sex with men and 252 men who have sex with women showed the One Male Condom has a failure rate of 0.68 percent for anal sex and 1.89 percent for vaginal sex.

The recently approved condoms may be a useful tool for HIV/AIDS prevention, according to Dr. Will DeWitt, clinical director of anal health at the Callen-Lorde Community Health Center in New York City.

The expectation is that people will be more willing to use condoms for anal intercourse, and having that explicit encouragement will boost the number of people who use them, according to DeWitt. For those who cannot or do not want to utilize PrEP, condoms are still a crucial tool.

Pre-exposure prophylaxis, or PrEP, is frequently taken as a daily medication to prevent HIV/AIDS in patients who have not yet been given a diagnosis of the virus. The FDA also authorized an injectable PrEP shot last year that can be administered every two months.

DeWitt did however add that he is concerned that the promotion for the One Male Condom may turn off those who engage in anal intercourse but do not identify as men.

Everyone should be able to have anal intercourse, according to DeWitt. Even from the standpoint of who has to use a condom, more people than only male bodies and people who identify as men need to do so.

Although medical professionals have long advocated using condoms to prevent STIs during anal sex like in sex viet nam, DeWitt claimed that the FDA's official approval is long overdue. pornsexzone.com